Oral semaglutide in patients with type 2 diabetes and cardiovascular disease, renal impairment, or other comorbidities, and in older patients
O Mosenzon, EM Miller, ML Warren - Postgraduate Medicine, 2020 - Taylor & Francis
Patients with type 2 diabetes (T2D) often have comorbidities, such as cardiovascular
disease or chronic kidney disease, and a large and growing proportion of the T2D patient …
disease or chronic kidney disease, and a large and growing proportion of the T2D patient …
Oral semaglutide in patients with type 2 diabetes and cardiovascular disease, renal impairment, or other comorbidities, and in older patients
O Mosenzon, EM Miller… - Postgraduate …, 2020 - pubmed.ncbi.nlm.nih.gov
Patients with type 2 diabetes (T2D) often have comorbidities, such as cardiovascular
disease or chronic kidney disease, and a large and growing proportion of the T2D patient …
disease or chronic kidney disease, and a large and growing proportion of the T2D patient …
Oral semaglutide in patients with type 2 diabetes and cardiovascular disease, renal impairment, or other comorbidities, and in older patients.
O Mosenzon, EM Miller, ML Warren - Postgraduate Medicine, 2020 - europepmc.org
Patients with type 2 diabetes (T2D) often have comorbidities, such as cardiovascular
disease or chronic kidney disease, and a large and growing proportion of the T2D patient …
disease or chronic kidney disease, and a large and growing proportion of the T2D patient …